Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Monthly BPC-157 treatment costs range from $150-300 through licensed telehealth providers in 2026, including consultations and peptide supplies
Clinical Evidence Human Trials: A randomized, placebo-controlled study in obese adults demonstrated that AOD-9604 significantly reduced abdominal and total body fat over several weeks of treatment, without serious side effects Animal Studies: Preclinical studies in mice and rats showed that AOD-9604: Stimulated lipolysis Inhibited lipogenesis (formation of new fat) Prevented weight gain despite high-fat diets This dual actionenhancing fat breakdown and inhibiting fat formationpositions AOD-9604 as a potent tool for combating obesity
This phase quickly fills up the bodys vitamin B12 stores
A US cGMP contract manufacturer
US$ 28.52
US$ 28.04
US$ 21.07
US$ 25.65
US$ 21.09
US$ 29.49
US$ 20.63
